YU3103A - 2,2-disupstituisani 1,3-dioksolani kao sredstva protiv kašlja - Google Patents

2,2-disupstituisani 1,3-dioksolani kao sredstva protiv kašlja

Info

Publication number
YU3103A
YU3103A YU3103A YUP3103A YU3103A YU 3103 A YU3103 A YU 3103A YU 3103 A YU3103 A YU 3103A YU P3103 A YUP3103 A YU P3103A YU 3103 A YU3103 A YU 3103A
Authority
YU
Yugoslavia
Prior art keywords
dioxolanes
disubstituted
antitussive agents
piperazinyl
phenyl
Prior art date
Application number
YU3103A
Other languages
English (en)
Inventor
Marcello Allegretti
Maria Candida Cesta
Roberto Curti
Lica Nicolini
Original Assignee
Dompe S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe S.P.A. filed Critical Dompe S.P.A.
Publication of YU3103A publication Critical patent/YU3103A/sh
Publication of RS50862B publication Critical patent/RS50862B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Holo Graphy (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Secondary Cells (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Fats And Perfumes (AREA)
  • Liquid Crystal Substances (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Glass Compositions (AREA)

Abstract

Opisani su ciklični acetali (S)-3-(4-fenil-1-piperazinil)-1,2- propandiola koji se koriste kao sredstva protiv kašlja i kao intermedijeri za dobijanje levodropropizina i njegovih soli, kao i procesa za dobijanje pomenutih actala.[3-(4-Phenyl-1-piperazinyl)-1,2-propanediol cyclic acetals, a process for the optical resolution thereof and their use as intermediates for the prepartion of (-) 3-(4-phenyl-1-piperazinyl)-1,2-propanediol (levodropropizine) and salts thereof
YUP-31/03A 2000-07-28 2001-07-18 2,2-disupstituisani 1,3-dioksolani kao sredstva protiv kašlja RS50862B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI001735A IT1318651B1 (it) 2000-07-28 2000-07-28 Sintesi di (+-)1,3-diossolani e loro risoluzione ottica.

Publications (2)

Publication Number Publication Date
YU3103A true YU3103A (sh) 2006-05-25
RS50862B RS50862B (sr) 2010-08-31

Family

ID=11445592

Country Status (25)

Country Link
US (1) US6916926B2 (sh)
EP (1) EP1307440B1 (sh)
JP (1) JP5015403B2 (sh)
KR (1) KR100788532B1 (sh)
CN (1) CN1216053C (sh)
AT (1) ATE290533T1 (sh)
AU (1) AU2001281992A1 (sh)
BR (1) BR0112802A (sh)
CZ (1) CZ301039B6 (sh)
DE (1) DE60109299T2 (sh)
EE (1) EE05159B1 (sh)
ES (1) ES2237589T3 (sh)
HK (1) HK1058798A1 (sh)
HU (1) HU229801B1 (sh)
IL (2) IL153502A0 (sh)
IT (1) IT1318651B1 (sh)
MX (1) MXPA02012922A (sh)
PL (1) PL206308B1 (sh)
PT (1) PT1307440E (sh)
RS (1) RS50862B (sh)
RU (1) RU2269522C2 (sh)
SI (1) SI21041B (sh)
SK (1) SK286795B6 (sh)
UA (1) UA73790C2 (sh)
WO (1) WO2002010150A1 (sh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318650B1 (it) * 2000-07-28 2003-08-27 Dompe Spa 1,3-diossolani ad attivita' antitosse.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049660A (en) * 1971-06-18 1977-09-20 Delalande S.A. N-substituted derivatives of 4 (N-piperazinylmethyl) spiro dibenzocycloheptadi- (or tri-) ene-5, 2-dioxolane (1,3) their method of preparation and their application in therapeutics
IT1210639B (it) * 1981-02-25 1989-09-14 Menarini Sas Prodotto: 3(4-fenil1piperazinio-1-il)-1,2-propandiolo 3(teofillin-7-il)-1propansolfonato,utilizzabile in terapia,e relativo procedimento di fabbricazione
IT1203721B (it) * 1983-12-29 1989-02-23 Dompe Farmaceutici Spa Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono
SE449516B (sv) * 1984-10-16 1987-05-04 Skf Nova Ab Klemring med reglerbar halomkrets
IT1254452B (it) * 1992-02-14 1995-09-25 Dompe Farmaceutici Spa N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
IT1318650B1 (it) * 2000-07-28 2003-08-27 Dompe Spa 1,3-diossolani ad attivita' antitosse.

Also Published As

Publication number Publication date
SI21041A (sl) 2003-04-30
KR100788532B1 (ko) 2007-12-24
EP1307440A1 (en) 2003-05-07
PL206308B1 (pl) 2010-07-30
PL361173A1 (en) 2004-09-20
JP2004505074A (ja) 2004-02-19
CN1444579A (zh) 2003-09-24
CZ2003269A3 (cs) 2003-06-18
BR0112802A (pt) 2003-07-01
ES2237589T3 (es) 2005-08-01
EP1307440B1 (en) 2005-03-09
UA73790C2 (uk) 2005-09-15
RU2269522C2 (ru) 2006-02-10
US20030176446A1 (en) 2003-09-18
JP5015403B2 (ja) 2012-08-29
SI21041B (en) 2005-08-31
ITMI20001735A1 (it) 2002-01-28
PT1307440E (pt) 2005-05-31
CZ301039B6 (cs) 2009-10-21
EE05159B1 (et) 2009-04-15
IL153502A (en) 2006-12-10
US6916926B2 (en) 2005-07-12
MXPA02012922A (es) 2003-10-06
DE60109299T2 (de) 2005-07-21
CN1216053C (zh) 2005-08-24
AU2001281992A1 (en) 2002-02-13
HK1058798A1 (en) 2004-06-04
DE60109299D1 (de) 2005-04-14
HUP0301473A2 (hu) 2003-08-28
ITMI20001735A0 (it) 2000-07-28
KR20030016424A (ko) 2003-02-26
ATE290533T1 (de) 2005-03-15
SK902003A3 (en) 2003-09-11
IL153502A0 (en) 2003-07-06
EE200300035A (et) 2004-10-15
SK286795B6 (sk) 2009-05-07
HU229801B1 (en) 2014-07-28
IT1318651B1 (it) 2003-08-27
RS50862B (sr) 2010-08-31
WO2002010150A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
DK0776324T3 (da) Endothelin-antagonister
EA200300459A1 (ru) Новые, применяемые в качестве медикаментов антихолинергические средства, а также способ их получения
MX9603050A (es) Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas.
ATE211732T1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
ES2053094T3 (es) Agentes ansioliticos y antidepresivos bis-aza-biciclicos.
YU3103A (sh) 2,2-disupstituisani 1,3-dioksolani kao sredstva protiv kašlja
FI95247C (fi) Menetelmä lääkeaineina käytettävien 1,3-tiatsolidinien -karbonyylikarboksiamidien valmistamiseksi
TR200402546T4 (tr) Taksan türevleri hazırlamak için işlem.
HK1058797A1 (en) 1,3-Dioxolanes with antitussive activity.
EA200201003A1 (ru) Аморфная модификация торасемида
ATE150453T1 (de) Verfahren zur herstellung von trans-piperidin-2,5-dicarboxylaten
EP0785191A4 (en) INDANE FUSION DERIVATIVES AND THEIR SALTS
ATE299489T1 (de) Aminderivate und verfahren zu ihrer herstellung
FI880987A0 (fi) 1-(1-aryl-2-hydroxietyl) imidazoler och deras salter, foerfarande foer deras framstaellning, laekemedel innehaollande dessa foereningar och deras anvaendning.
EA200200090A1 (ru) Способ получения замещенных бензизотиазоловых соединений
DE3683352D1 (de) Verfahren zur herstellung von indolinen.